Colgate-Palmolive (NYSE:CL – Get Free Report) had its price objective increased by research analysts at Morgan Stanley from $101.00 to $103.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s target price would suggest a potential upside of 12.20% from the stock’s current […]